Lactocore Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Series A
  • (In Progress)

  • Investors
  • 3

Lactocore General Information

Description

Developer of a peptide-based medications designed for mental, metabolic, and age-related disorders. The company offers rapid onset and minimal adverse effects, as demonstrated in animal models, promoting neuroplasticity and balancing excitatory-inhibitory signals in the brain, enabling baby food manufacturers to reduce the risk of motor mental retardation through their food product.

Contact Information

Website
www.lactocore.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 320 Nevada Street
  • Newton, MA 02460
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Life Sciences
Corporate Office
  • 320 Nevada Street
  • Newton, MA 02460
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lactocore Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series A) 16-Aug-2024 In Progress Generating Revenue
3. Accelerator/Incubator 17-Apr-2024 Completed Startup
2. Accelerator/Incubator 31-Jul-2023 Completed Startup
1. Accelerator/Incubator 01-Dec-2022 Completed Startup
To view Lactocore’s complete valuation and funding history, request access »

Lactocore Patents

  • 12

    Total Documents Applications and Grants

  • Total Patents Families

  • 4

    Granted

  • 5

    Pending

  • Expiring in next 12 mo

Lactocore Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021256034-A1 Synthetic peptides for modulating the metabotropic glutamate receptor 5 Inactive 15-Apr-2020
EP-4135741-A1 Synthetic peptides for modulating the metabotropic glutamate receptor 5 Inactive 15-Apr-2020
CA-3175267-A1 Synthetic peptides for modulating the metabotropic glutamate receptor 5 Pending 15-Apr-2020
US-20230140798-A1 Synthetic peptides directed against the metabotropic glutamate receptor 5 Pending 15-Apr-2020
EP-4135741-A4 Synthetic peptides for modulating the metabotropic glutamate receptor 5 Inactive 15-Apr-2020 C07K5/1008
To view Lactocore’s complete patent history, request access »

Lactocore Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lactocore Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
EIT Health Accelerator/Incubator
Biolabs Corporation Minority
German Accelerator Accelerator/Incubator
To view Lactocore’s complete investors history, request access »

Ready to get started?

Request a free trial

Lactocore FAQs

  • When was Lactocore founded?

    Lactocore was founded in 2018.

  • Where is Lactocore headquartered?

    Lactocore is headquartered in Newton, MA.

  • What is the size of Lactocore?

    Lactocore has 6 total employees.

  • What industry is Lactocore in?

    Lactocore’s primary industry is Biotechnology.

  • Is Lactocore a private or public company?

    Lactocore is a Private company.

  • What is Lactocore’s current revenue?

    The current revenue for Lactocore is .

  • Who are Lactocore’s investors?

    EIT Health, Biolabs, and German Accelerator have invested in Lactocore.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »